1. Home
  2. ALT vs VREX Comparison

ALT vs VREX Comparison

Compare ALT & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • VREX
  • Stock Information
  • Founded
  • ALT 1997
  • VREX 2016
  • Country
  • ALT United States
  • VREX United States
  • Employees
  • ALT N/A
  • VREX N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • VREX Industrial Machinery/Components
  • Sector
  • ALT Health Care
  • VREX Technology
  • Exchange
  • ALT Nasdaq
  • VREX Nasdaq
  • Market Cap
  • ALT 397.4M
  • VREX 343.3M
  • IPO Year
  • ALT N/A
  • VREX N/A
  • Fundamental
  • Price
  • ALT $4.16
  • VREX $7.73
  • Analyst Decision
  • ALT Strong Buy
  • VREX Strong Buy
  • Analyst Count
  • ALT 6
  • VREX 2
  • Target Price
  • ALT $18.20
  • VREX $22.50
  • AVG Volume (30 Days)
  • ALT 11.4M
  • VREX 373.8K
  • Earning Date
  • ALT 08-07-2025
  • VREX 07-31-2025
  • Dividend Yield
  • ALT N/A
  • VREX N/A
  • EPS Growth
  • ALT N/A
  • VREX N/A
  • EPS
  • ALT N/A
  • VREX N/A
  • Revenue
  • ALT $20,000.00
  • VREX $827,500,000.00
  • Revenue This Year
  • ALT N/A
  • VREX $0.73
  • Revenue Next Year
  • ALT $1,557,547.90
  • VREX $4.40
  • P/E Ratio
  • ALT N/A
  • VREX N/A
  • Revenue Growth
  • ALT N/A
  • VREX N/A
  • 52 Week Low
  • ALT $2.90
  • VREX $6.76
  • 52 Week High
  • ALT $11.16
  • VREX $16.93
  • Technical
  • Relative Strength Index (RSI)
  • ALT 40.54
  • VREX 39.20
  • Support Level
  • ALT $4.07
  • VREX $8.28
  • Resistance Level
  • ALT $4.79
  • VREX $8.69
  • Average True Range (ATR)
  • ALT 0.45
  • VREX 0.38
  • MACD
  • ALT -0.10
  • VREX -0.07
  • Stochastic Oscillator
  • ALT 28.16
  • VREX 8.81

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

Share on Social Networks: